139 related articles for article (PubMed ID: 32613384)
1. Reproducibility of cardiac magnetic resonance imaging in patients referred for the assessment of cardiac sarcoidosis; implications for clinical practice.
Juneau D; Nery PB; Pena E; Inácio JR; Beanlands RSB; deKemp RA; Alhajari ZM; Spence S; Medor MC; Dwivedi G; Birnie D
Int J Cardiovasc Imaging; 2020 Nov; 36(11):2199-2207. PubMed ID: 32613384
[TBL] [Abstract][Full Text] [Related]
2. Inter- and Intraobserver Agreement of
Ohira H; Ardle BM; deKemp RA; Nery P; Juneau D; Renaud JM; Klein R; Clarkin O; MacDonald K; Leung E; Nair G; Beanlands R; Birnie D
J Nucl Med; 2017 Aug; 58(8):1324-1329. PubMed ID: 28254873
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
5. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.
Vita T; Okada DR; Veillet-Chowdhury M; Bravo PE; Mullins E; Hulten E; Agrawal M; Madan R; Taqueti VR; Steigner M; Skali H; Kwong RY; Stewart GC; Dorbala S; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2018 Jan; 11(1):e007030. PubMed ID: 29335272
[TBL] [Abstract][Full Text] [Related]
6. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study.
Aikawa T; Oyama-Manabe N; Naya M; Ohira H; Sugimoto A; Tsujino I; Obara M; Manabe O; Kudo K; Tsutsui H; Tamaki N
Eur Radiol; 2017 Oct; 27(10):4054-4063. PubMed ID: 28382537
[TBL] [Abstract][Full Text] [Related]
7. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Cardiac Magnetic Resonance Strain Analysis for Detection of Cardiac Sarcoidosis.
Dabir D; Meyer D; Kuetting D; Luetkens J; Homsi R; Pizarro C; Nadal J; Thomas D
Rofo; 2018 Aug; 190(8):712-721. PubMed ID: 30045396
[TBL] [Abstract][Full Text] [Related]
9. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of cardiac magnetic resonance imaging for cardiac sarcoidosis in complete heart block patients implanted with magnetic resonance-conditional pacemaker.
Orii M; Tanimoto T; Ota S; Takagi H; Tanaka R; Fujiwara J; Akasaka T; Yoshioka K
J Cardiol; 2020 Aug; 76(2):191-197. PubMed ID: 32184028
[TBL] [Abstract][Full Text] [Related]
11. Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis.
Okada DR; Xie E; Assis F; Smith J; Derakhshan A; Gowani Z; Ambale-Venkatesh B; Gilotra NA; Zimmerman SL; Berger RD; Calkins H; Lima JAC; Tandri H; Chrispin J
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1967-1976. PubMed ID: 31328324
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation.
Muser D; Santangeli P; Liang JJ; Castro SA; Magnani S; Hayashi T; Garcia FC; Frankel DS; Dixit S; Zado ES; Lin D; Desjardins B; Callans DJ; Alavi A; Marchlinski FE
JACC Clin Electrophysiol; 2018 Mar; 4(3):291-303. PubMed ID: 30089553
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.
Coleman GC; Shaw PW; Balfour PC; Gonzalez JA; Kramer CM; Patel AR; Salerno M
JACC Cardiovasc Imaging; 2017 Apr; 10(4):411-420. PubMed ID: 27450877
[TBL] [Abstract][Full Text] [Related]
14. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
15. QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
Sobue Y; Harada M; Koshikawa M; Ichikawa T; Yamamoto M; Okuda K; Kato Y; Sarai M; Watanabe E; Ozaki Y
Heart Rhythm; 2015 Dec; 12(12):2499-507. PubMed ID: 26362576
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
Sgard B; Brillet PY; Bouvry D; Djelbani S; Nunes H; Meune C; Valeyre D; Soussan M
Clin Radiol; 2019 Jan; 74(1):81.e9-81.e18. PubMed ID: 30482560
[TBL] [Abstract][Full Text] [Related]
20. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
